Integra Lifesciences Sees Q4 EPS $0.82-$0.86 Vs. $0.81 Est. Sales $403M Vs. $409.65M Est.; Raises FY21 EPS Guidance From $2.98-$3.05 To $3.16-$3.20 Vs. $3.02 Est.